I-Mab Announces Upcoming Participation at April Conferences

NEXT STORY
Generex Biotechnology CEO Offers an Open Letter to Shareholders and Provides an Update on Corporate Response to the COVID-19 Pandemic
PREV STORY
American BriVision Conducts Site Monitoring Visit for Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AXIM® Biotechnologies Unveils First–in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization with the FDA

author_avatar
NASDAQ Market News

Novel late-stage colorectal cancer treatment proves effective in preclinical models

author_avatar
NASDAQ Market News

Publishing of Orion Corporation’s Half-Year Financial Report for January-June 2018 on 18 July 2018

ORION CORPORATION                     PRESS RELEASE                   5 JULY 2018 at 11.30 EESTPublishing of Orion Corporation's Half-Year ...

author_avatar
NASDAQ Market News